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Abstract
The melibiose carrier of E. coli is a cation-sugar cotransport system. This membrane protein contains four cysteine
residues and the transport function is inhibited by sulfhydryl reagents. In order to investigate the importance of the
cysteines, we have constructed a set of four melibiose transporters each of which has one cysteine replaced with serine or
valine. The sensitivity of this set of carriers to N-ethylmaleimide was tested and Cys364 was identified as the target of the
reagent. In addition, we constructed a melibiose transporter in which all 4 cysteines were replaced with either serine
 .  .Cys110, Cys310, and Cys364 or valine Cys235 and we found that, as expected, the resulting cysteine-less transporter
was resistant to the action of N-ethylmaleimide. The cysteine-less melibiose carrier had no significant decrease in ability to
accumulate melibiose with cotransported sodium ions or protons. Thus, none of the 4 cysteines are necessary for the
function of the melibiose carrier. q 1997 Elsevier Science B.V.
 .Keywords: Melibiose carrier; Cysteine; Mutagenesis; E. coli
1. Introduction
The melibiose transporter of E. coli is an integral
membrane protein that facilitates the transport and
accumulation of a-galactosides or b-galactosides into
the cell. This symporter is unusual in that it can
 q q q.utilize a variety of cations H , Na , or Li , as the
 w x.cotransported ion see reviews 1–3 . The gene for
 .the E. coli protein melB has been sequenced by
w xYazyu et al. 4 and the protein has been overex-
w xpressed and purified by Pourcher et al. 5 . The
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hydropathy profile as well as experiments with phoA
w xfusions 6,7 provide information about the two-di-
mensional structure of the melibiose carrier and sug-
gest that the carrier possesses 12 transmembrane
a-helices. The reaction of inside-out vesicles with an
antibody prepared against the carboxyl-terminus of
the protein demonstrates that this end of the protein
w xextends into the cytoplasm 8 .
Mutant selections and site-directed mutagenesis
have begun to provide data on the specific amino
acids and domains of the melibiose carrier that are
important for its function. The clustering of mutants
with altered sugar andror cation specificity within
the first 4 proposed transmembrane helices, helix 7,
helices 10 and 11, and the loop between helices 10
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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and 11, strongly suggest a close interaction of these
regions in the three-dimensional structure of the meli-
biose carrier. For example, the four aspartic acid
 .residues at positions 19, 55, 59, and 124 in mem-
brane-spanning helices 1, 2, and 4 appear to be
q w x important for Na cotransport 9,10 and Asn58 helix
. q2 has been identified as important in Na specificity
w x11,12 . Additional mutants with altered sugar andror
cation specificity had amino acid changes in trans-
membrane helices 1, 4, 7, 10, and 11 and in the
w xcytoplasmic loop between helices 10 and 11 13–15 .
The study of naturally occurring cysteines or those
re-introduced by site-directed mutagenesis into func-
tional cysteine-less transporters has yielded informa-
tion about the route of the substrate through a variety
of bacterial membrane carriers. The experimental
finding that the substrates of transporters prevent
inhibition of transport by sulfhydryl reagents suggests
that the targeted cysteines are in the path that the
substrate takes through the carrier. The targeted cys-
teines could directly participate in the binding of the
substrate during its transit or the modified cysteine
could physically block access to the transport path
w x16–20 . In addition, the reaction of cysteines with
hydrophilic, membrane impermeant sulfhydryl
reagents presented to right-side-out or inside-out
membranes and the resulting effect on transport func-
tion has provided further evidence for the identifica-
Fig. 1. Relative location of cysteines on the topographic map of
the melibiose transporter. The 12 transmembrane segments that
are predicted from hydropathy profiles and from alkaline phos-
w xphatase fusion proteins 6,7 are shown with the amino and
carboxyl termini of the protein oriented to the inside of the cell
w x8 . The relative location of the 4 cysteines either in the trans-
membrane segments or in a cytoplasmic loop are as designated.
tion of amino acids that line the channel through
w xwhich the transporter’s substrate moves 17–20 .
The melibiose transporter has 4 cysteines at residue
number 110, 235, 310, and 364 as depicted schemati-
cally in Fig. 1. The first 3 cysteines are located in
helices 4, 7, and 9 respectively, whereas Cys364 is
located in the cytoplasmic loop between helices 10
and 11. Previously, the inhibition of melibiose trans-
port by sulfhydryl reagents was shown by Cohn et al.
w x21 to be partially prevented by the presence of
substrate. However, substrate binding p-nitro-
.phenyl-a-galactoside was unaffected by sulfhydryl
w xreagents 22 . In this communication we construct a
set of 4 melibiose carriers each of which has one of
the 4 cysteines changed to serine or valine. The effect
that the elimination of a single cysteine has on trans-
port and on inhibition of transport by N-ethylmalei-
mide is determined. A cysteine-less melibiose carrier
is also constructed and its transport capabilities are
analyzed.
2. Materials and methods
2.1. Reagents
M elibiose 6-O -a -D-galactopyranosyl-D-
. glucopyranoside , TMG methyl-1-thio-b-D-galacto-
.pyranoside , and lactose were purchased from Sigma.
w3 xH Melibiose was a generous gift from Dr. Gerard
Leblanc of the Departement de Biologie Cellulaire et´
Moleculaire du CEA, Villefranche-sur-mer, France.´
w14 x wC TMG was purchased from Dupont-NEN. a-
33 x w35 xP dATP was from Andotek and S Protein A was
purchased from Amersham. Bacteriological media
 .were from Difco. N-ethylmaleimide NEM was from
Sigma.
2.2. Bacterial strains and plasmids
 q . w xE. coli DW1 lacI DlacZY DmelAB 23 was
used as the host strain for the plasmids when bacteria
were grown for sugar transport assays, sugar-stimu-
lated Hq and Naq uptake, and immunoblot experi-
w xments. The plasmid, pKKMB 24 , that contains the
gene for the temperature resistant form of the meli-
biose carrier inserted into the vector pKK223-3
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 .Pharmacia Biotech was used as the source of the
melB gene into which the mutations were introduced.
2.3. Site-directed mutagenesis
The mutagenic oligonucleotides that are listed in
Table 1 were used to replace the cysteine codons at
positions 110, 310, and 364 with serine codons and
the cysteine codon at position 235 by a valine codon
in the temperature resistant melB gene of E. coli that
is contained in the plasmid, pKKMB. Three of the
individual substitutions for cysteine at positions 110,
.310, and 364 were constructed by the method of
w xTaylor et al. 25,26 in an M13 derivative that con-
tained the melB gene from pKKMB. The cysteine-less
melibiose carrier was constructed with the Muta-Gene
 .M13 in vitro Mutagenesis Kit Bio-Rad using the
M13 derivative just described. The Cys235 to valine
substitution was constructed with the Chameleon
Double-stranded Site-directed Mutagenesis Kit
 .Stratagene .
2.4. DNA sequencing
Double-stranded plasmid DNA was isolated with a
 .QIAprep Spin Miniprep Kit Qiagen . DNA was
sequenced with the AmpliCycle Sequencing Kit Per-
.kin Elmer .
2.5. Immunodetection of the melibiose carrier in
bacterial cells
w xThe method of Lolkema et al. 27 was used to
detect the presence of melibiose carrier in bacterial
cells lysed on nitrocellulose filters. The amount of
polyclonal antibody that was bound to the carboxyl-
w xterminus of the melibiose transporter 8 was quanti-
w35 xtated with S Protein A.
Table 1
Oligonucleotide primers used for site-directed mutagenesis
Oligonucleotide Sequence
X XpC110S 5 -GGTCACGCtAACAAAGA-3
X XpC235V 5 -CCCAAGAGgaCTGAAAGC-3
X XpC310S 5 -AACACCACtGCTTAACA-3
X XpC364S 5 -ACTTTCACtGCGTACGT-3
2.6. Transport of sugars
Cells of DW1 containing a plasmid with either a
normal or a mutant melB gene were grown overnight
in LB medium that contained ampicillin at 100 mg
mly1. In the morning, cells were diluted 50-fold and
grown to mid-log phase at 378C. Cells were harvested
by centrifugation, washed twice with 100 mM MOPS
buffer that was adjusted to pH 7.0 with Tris base and
that contained 0.5 mM MgSO . The cells were resus-4
pended in a volume of the same buffer to give a cell
y1 density corresponding to about 1 mg dry wt ml ca.
9 y1.6=10 cells ml . The transport reaction was
started by the addition of radioactive sugar to the cell
suspension that had been equilibrated to 228C and, in
experiments with sodium-coupled transport, equili-
brated with 10 mM NaCl. At given time intervals,
cell samples were filtered rapidly through 0.65 mm
 .pore size nitrocellulose filters Sartorius and washed
with 5 ml buffer. The filters were transferred to
 .Liquiscint National Diagnostics and were counted
in a liquid scintillation counter.
2.7. Sodium uptake
Sodium uptake was measured with a sodium-
 .specific electrode Radiometer Copenhagen G502Na
w xas described by Franco and Wilson 12 . The final
y1  10cell density was 4–5 mg dry wt ml ca. 2=10
y1.cells ml and the final melibiose concentration was
5 mM.
2.8. Proton uptake
Uptake of protons was measured with a pH elec-
 .trode Radiometer GK2321-C by the method of West
w x28 . Cell preparation in sodium free buffer was as
w xdescribed in Franco and Wilson 12 with the final
y1  10cell density at 4–5 mg dry wt ml ca. 2=10
y1.cells ml and the final melibiose concentration at
3.3 mM.
2.9. Inhibition of transport by N-ethylmaleimide
 y1.The cell suspension 1–1.5 mg dry wt ml that
was prepared as described for the transport of sugars
was incubated with 0.5 mM N-ethylmaleimide for 10
min at 228C. Dithiothreitol was then added to a final
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concentration of 10 mM and the cells were tested for
their ability to transport melibiose. For the mock
treatment with N-ethylmaleimide, the dithiothreitol
and N-ethylmaleimide were preincubated together for
10 min before the cells were added.
3. Results
3.1. Replacement of one or all cysteines in the meli-
biose carrier with serine or ˝aline
The temperature resistant, wild type melB gene
was used as the target of oligonucleotide site-directed
mutagenesis as described in Materials and Methods.
Four melibiose carriers of E. coli were constructed
and each had a single cysteine changed to either
 . serine residue 110, 310 and 364 or valine residue
.235 . Initially Cys235 was also changed to serine but
this substitution resulted in a substantially reduced
amount of transporter in the membrane: to 20% of
the wild type amount. The replacement of all the
cysteines by serine or valine was accomplished by 4
successive rounds of mutagenesis. The complete DNA
sequence of all of the final plasmid constructs was
determined to verify the presence of only the desired
mutations.
3.2. Analysis of the relati˝e amount of melibiose
carrier produced by the melB genes with cysteine
codon replacements
The relative amount of melibiose carrier present in
the bacterial cell was analyzed with a polyclonal
antibody directed against the carboxyl-terminus of
the protein. The antibody reacting with a known
quantity of lysed cells on a nitrocellulose filter was
detected with radiolabeled Protein A as described in
Section 2. As seen in Fig. 2, the alleles of melB that
had mutations resulting in the replacement of either a
single cysteine codon or all cysteine codons with a
serine or valine codon produced an amount of carrier
protein that was very similar to the amount produced
by the original, wildtype gene.
3.3. Kinetic analysis of sodium-coupled sugar trans-
port
The effect of the cysteine replacements in the
melibiose carrier on the kinetics of sodium-coupled
Fig. 2. Immunodetection of the relative amount of melibiose
carrier. Melibiose carrier in bacteria harboring a plasmid with
either a wild type or cysteine replacement melB gene was
detected as described in Section 2 by using a polyclonal antibody
directed against the carboxyl-terminus of the protein. The results
are the average of 3–4 experiments with 4 data points per
experiment.
accumulation of thiomethyl-b-galactoside or meli-
biose was examined. After trial experiments gave an
estimated value for the K , seven different concen-m
trations of sugar were selected that bracketed the
estimate. The accumulation of sugar by the plasmid-
harboring cells was then measured at each selected
concentration after a 15 s incubation. The resulting
data were analyzed by the double-reciprocal plot of
Michaelis and Menten and the values for K andm
V were determined from the best fitting line thatmax
was obtained by linear regression analysis of the
points. The results are presented in Table 2. The
replacement of a single cysteine by serine or valine
had little or no effect on the K of the melibiosem
carrier for either thiomethyl-b-galactoside or meli-
biose. The V of accumulation also was essentiallymax
unchanged except when thiomethyl-b-galactoside was
the transported sugar for the two constructions that
had the C364S replacement. In these two cases, the
V was reduced to 24% of the wild type valuemax
when Cys364 was replaced with serine and was
reduced to 49% of the wild type value in the cys-
teine-less melibiose carrier. However, when the Vmax
of sodium-coupled accumulation of melibiose was
determined, the cysteine-less melibiose transporter
 .shows only a modest to 75% of the wild-type value
decrease compared to the wild type carrier.
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Table 2
Kinetic constants for sodium-coupled transport
melB TMG Melibiose
K V K Vm max m max
y1 y1 y1 y1mM nmol min mg mM nmolmin mg
Wild type 0.07 76 0.3 120
C110S 0.08 77 0.3 110
C235V 0.07 97 0.2 100
C310S 0.06 71 0.2 85
C364S 0.1 18 0.2 120
Cys-less 0.1 37 0.3 89
Cells preparation and transport assays were as described in Section 2. Accumulation of sugar after 15 s was measured at 7 concentrations
of radiolabeled thiomethyl-b-galactoside in the range of 20–400 mM or at 7 concentrations of radiolabeled melibiose in the range of
56–800 mM. The values for K and V are the average of at least 2 separate experiments with duplicate data points in eachm max
experiment.
3.4. Measurement of proton-coupled melibiose accu-
mulation
 .  .The initial rate at 15 s and steady state at 5 min
level of proton-coupled melibiose accumulation by
the wild-type and the cysteine-replacement melibiose
carriers is presented in Table 3. All of the cysteine-
replacement strains tested can accumulate melibiose
at least as well as the wild-type carrier. The melibiose
carriers with a single cysteine replacement all show a
slightly elevated initial rate of accumulation and,
except for the C364S carrier, a slightly elevated
steady state level of accumulation. The cysteine-less
melibiose carrier has an initial rate of accumulation
Table 3
Initial rate and steady state proton-coupled accumulation of meli-
biose
w x w xmelB melibiose r melibiosein out
15 s 5 min
Wild type 1.6 4.7
C110S 2.3 5.7
C235V 2.3 6.2
C310S 2.1 4.8
C364S 2.0 7.2
Cys-less 1.6 9.0
Cell preparation and transport assays were as described in Sec-
tion 2. The concentration of radiolabeled melibiose was 0.8 mM.
The concentration of melibiose in the cell was calculated by
assuming a cell volume of 0.4 ml for every 1=109 cells. The
data are the results of at least 2 experiments with duplicate
determinations in each experiment.
the same as wild-type whereas the steady state level
of accumulation is ca. 1.9 times wild type.
3.5. Measurement of melibiose-stimulated sodium up-
take
The cotransport of sodium into the cell along with
sugar can be measured with a sodium specific elec-
trode as a decrease in external sodium concentration.
The time course and magnitude of the change in
Fig. 3. Melibiose stimulated sodium uptake by bacteria harboring
a plasmid with a wild type or mutant melB gene. Sodium
movement was measured by a sodium electrode as described in
Section 2 after addition of melibiose to a final concentration of 5
mM. Addition of 60 nmol of NaCl to the cell suspension resulted
in an electrode response as indicated.
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external sodium concentration upon melibiose uptake
was thus compared among the various cysteine-re-
placement strains. Fig. 3 depicts the time course of
the decrease in external sodium concentration of the
wild-type and mutant carriers upon addition of meli-
 .biose to a final concentration of 5 mM to the cell
suspension. The C110S, C235V, and C310S replace-
ments in the melibiose carrier all resulted in a carrier
that gave sodium movement similar to that of the
wild-type carrier. The C364S substitution in the car-
rier resulted in a somewhat larger movement of
sodium in response to melibiose compared to that
seen in the wild-type carrier. Elevated movement of
sodium was also seen with the cysteine-less meli-
biose carrier.
3.6. Measurement of melibiose-stimulated proton up-
take
The cotransport of protons into the cell along with
melibiose can be measured with a pH electrode as an
alkalinization of the cell suspension. The time course
and magnitude of the change in external pH was thus
measured as described in Section 2. Fig. 4 depicts the
Fig. 4. Melibiose stimulated proton uptake by bacteria harboring
a plasmid with a wild-type or mutant melB gene. Proton move-
ment was measured by a pH electrode as described in Section 2
after addition of melibiose to a final concentration of 3.3 mM.
Addition of 100 nmol of KOH to the cell suspension resulted in
an electrode response as indicated.
Table 4
Inhibition by N-ethylmaleimide of sodium-coupled melibiose
accumulation
melB Reagent Melibiose uptake % Inhibition
y1 y1nmol min mg
Wild type None 17.0 0
NEM 2.6 85
C110S None 21.1 0
NEM 5.3 75
C235V None 18.3 0
NEM 3.0 84
C310S None 17.3 0
NEM 1.5 91
C364S None 18.4 0
NEM 15.4 16
Cys-less None 15.1 0
NEM 13.1 13
Cell preparation and transport assays were as described in Sec-
tion 2. The concentration of radiolabeled melibiose was 0.1 mM
and accumulation was measured after 1 min. Each data point in
the table is the average of at least 3 experiments with triplicate
determinations in each experiment.
time course and magnitude of the external pH change
for the wild-type carrier and mutant carriers when
melibiose was added to the cell suspension to a final
concentration of 3.3 mM. The C110S, C310S, and
C364S replacements in the melibiose carrier all re-
sulted in carriers that gave a larger change in external
pH in response to melibiose compared to the wild-type
carrier. The C235V replacement gave a pH change
that was similar to wild type and the cysteine-less
carrier had somewhat reduced uptake of protons com-
pared to wildtype.
3.7. The target of N-ethylmaleimide in the melibiose
carrier
Previous studies of the melibiose carrier had
demonstrated that sulfhydryl reagents completely in-
w xhibited the transport activity 21,29,30 and that sub-
w xstrates only partially protected against inhibition 21 .
The construction of melibiose carriers with a single
cysteine removed could potentially allow the identifi-
cation of the cysteine responsible for the inhibitory
action of the sulfhydryl reagents. The set of melibiose
carriers that had a single cysteine replaced with an-
other amino acid were thus treated with N-ethyl-
maleimide as described in Section 2 and the ability of
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the treated carriers to accumulate melibiose in a
sodium-coupled reaction was then measured. The
results of these experiments are presented in Table 4.
The replacement of Cys110, Cys235, or Cys310 re-
sulted in a melibiose carrier that was still inhibited by
N-ethylmaleimide. However, the replacement of
Cys364 resulted in a carrier that now is largely
unaffected by the sulfhydryl reagent. The small
amount of inhibition of transport seen in the C364S
and cysteine-less carrier could be due to reaction with
amino or imide groups in the protein. It is unlikely
due to inhibition of the respiratory chain because the
addition of an alternate electron acceptor, reduced
w xphenazine methosulfate 31 , does not eliminate the
 .inhibition data not shown .
4. Discussion
We have constructed a set of 4 melibiose carriers
each of which has one cysteine changed to either
serine or valine. All of the mutant carriers exhibited
transport activity that was similar to that of the wild
type carrier. Elimination of Cys364 resulted in a
melibiose carrier that was now unaffected by N-
ethylmaleimide. The proposed topology of the meli-
biose carrier places Cys364 around the middle of a
cytoplasmic loop that is 29 amino acids long and is
w xbetween helices 10 and 11 7 . The loop between
helices 10 and 11 is also the location of mutants that
w xalter substrate or cation specificity 13 . Thus, this
cytoplasmic loop of the carrier appears to play a role
in the transport process. In contrast, the cysteines that
were identified as the targets of sulfhydryl reagents in
w xthe lactose permease 32,33 , the glucose-6-P an-
w x w xtiporter 17 , and the EmrE antiporter 20 are found
in regions of the protein that are assigned to trans-
membrane helices.
We have also constructed a melibiose carrier that
has either serine or valine substituted for all 4 of the
cysteines. The cysteine-less carrier exhibits apprecia-
ble sodium- or proton-coupled transport of sugars. In
fact, the cysteine-less carrier has kinetic constants for
the sodium-coupled accumulation of melibiose that
are similar to those of the wild-type carrier. Cysteines
are thus not essential for the transport of sugars by
the melibiose carrier. The lack of a requirement for
cysteinyl residues has been reported for the transport
of substrates by other bacterial carriers: the lactose
w x w xsymporter 34 , the glucose-6-P antiporter 17,18 ,
and the multidrug antiporter, EmrE, from E. coli,
w x20 . The sodium-coupled transport of thiomethyl-b-
galactoside, however, exhibited a reduction of the
V to 49% of the wild type value. A reduction tomax
.24% of the wild type value in the V for TMGmax
transport was also seen with the single C364S substi-
tution. In addition, the proton-coupled accumulation
of melibiose at steady-state was about 2-fold greater
with the cysteine-less carrier and the C364S carrier
than with the wild-type carrier. One possible explana-
tion for these results is that the recycling of the
 .carrier is altered in the cysteine-less and the C364S
carrier and thus alterations in the rate and level of
accumulation are seen with no alteration in the bind-
ing of sugar. Further experiments to measure the
component steps of the carrier cycle by measuring,
for example, efflux or entrance counterflow in de-en-
ergized cells would test this hypothesis. Diminished
efflux could also explain the elevated level of sodium
movement seen in both the cysteine-less and the
 .C364S carrier Fig. 3 . It is interesting to note that
w xPourcher et al. 35 have created mutants at Glu365
that show alterations in sugar efflux and exchange
without alterations in binding of the sugar. In light of
our current results and the past findings of others
w x13,35 , further investigation of the importance of this
cytoplasmic loop for the component steps of the
carrier cycle would be most interesting.
The construction of a fully functional melibiose
carrier that lacks cysteinyl residues now allows the
introduction of cysteines at defined positions within
the carrier. The susceptibility of these carriers to
inhibition by membrane-permeable or membrane-im-
permeable sulfhydryl reagents and the reversal of the
inhibition by substrates of the carrier allows the
identification of amino acids surrounding the path
that the transported sugar and accompanying cation
take through the membrane. Additionally, as Wu and
 w x. Kaback lac carrier, 36 and Lee et al. trg chemore-
w x.ceptor, 37 have, for example, demonstrated, the
introduction of two cysteines at defined locations and
determination of their susceptibility to crosslinkage
can address the question of what helices are adjacent
to one another in the three-dimensional structure of
the carrier in the membrane.
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